4 results
To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with international prognostic scoring system (IPSS) low or intermediate-1 risk MDS as measured by the number of clinically significant bleeding events.
Find/confirm percentage of remission after discontinuing TPO-RA in persistent and chronic ITP patients.
The purposes of this clinical trial are to:• Test if trial participants taking uproleselan with standard chemotherapy medicines live longer than those taking standard chemotherapy alone. • Test if the number of trial participants achieving disease…
To compare the blood pressure lowering effect of thiazides against calcium channel blockers in CNI-induced hypertension.